Announced Tue, 21 Jul · 15:30 IST
Board meeting on 14 Aug 2026 to consider Q1 FY27 results
Results View source PDF
ALKEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-1.3%1-day move
₹5684.50
prior close
₹5680.50
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.2-1.7-2.4-3.0-1.3-0.8-1.2———————
Up moveDown movePending
AI summary
Alkem Laboratories has informed BSE that its Board of Directors will meet on Friday, 14 August 2026 to consider and approve the standalone and consolidated unaudited financial results for the quarter ended 30 June 2026 (Q1 FY27). The intimation has been filed under Regulation 29 read with Regulation 33 of the SEBI Listing Regulations. No other agenda items have been disclosed at this stage.
Likely market impact
Routine quarterly results filing. Investors should watch for revenue, profit and margin numbers released after the 14 August meeting.